Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jnana Therapeutics
Biotech
Otsuka pays $800M for Jnana and its clinical-stage PKU drug
Otsuka has picked up Boston-based Jnana for $800 million so the Japanese biotech can get its hands on a clinical-stage oral phenylketonuria drug.
James Waldron
Aug 1, 2024 5:55am
Stanford president resigns—Chutes & Ladders
Jul 21, 2023 9:30am
Jnana Therapeutics brings in $107M funds, $2B Roche collab
Nov 15, 2022 6:00am
Moderna plucks Merck marketing head for CCO job—Chutes & Ladders
Apr 29, 2022 9:00am
Jnana nets $50M to push newly unveiled PKU program
Aug 18, 2021 7:00am
Nirogy emerges with $16.5M to target metabolite transporters
Jan 26, 2021 8:00am
